A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administration.

Loutfy, M R; Harris, M; Raboud, J M; Antoniou, T; Kovacs, C; Shen, S; Dufresne, S; Smaill, F; Rouleau, D; Rachlis, A; Gough, K; Lalonde, R; Tsoukas, C; Trottier, B; Walmsley, S L; Montaner, J S G

Loutfy, M R; Harris, M; Raboud, J M; Antoniou, T; Kovacs, C; Shen, S; Dufresne, S; Smaill, F; Rouleau, D; Rachlis, A; Gough, K; Lalonde, R; Tsoukas, C; Trottier, B; Walmsley, S L; Montaner, J S G.

Affiliation

Loutfy MR; Department of Medicine, University of Toronto, Maple Leaf Medical Clinic, and Department of Family and Community Medicine, St Michael's Hospital, Toronto, Ontario, Canada. Mona.Loutfy@wchospital.ca

HIV Med ; 8(7): 427-32, 2007 Oct.

Article in En | MEDLINE | ID: mdl-17760734

Subject(s)

HIV Envelope Protein gp41/administration & dosage; HIV Fusion Inhibitors/administration & dosage; HIV Infections/drug therapy; HIV; Peptide Fragments/administration & dosage; Adult; Area Under Curve; Enfuvirtide; Female; HIV Envelope Protein gp41/pharmacokinetics; HIV Fusion Inhibitors/pharmacokinetics; Humans; Injections/adverse effects; Male; Middle Aged; Patient Satisfaction; Peptide Fragments/pharmacokinetics; Prospective Studies; Quality of Life; Self Care; Therapeutic Equivalency

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / HIV Envelope Protein gp41 / HIV Infections / HIV / HIV Fusion Inhibitors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2007 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links